Viking Therapeutics, Inc. ($VKTX)
Filing Information
| Accession Number | 0001193125-26-003113 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
712,189
Total Value
$7,692,120.64
P&L
+inf% (+$15,478,957.40)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock, par value $0.00001 per share | โ | Jan 2, 2026 | Grant/Award | 78,400 | $0.00 | $0.00 | 2,508,620 | Direct | โ | View Details | |
Director | Common Stock, par value $0.00001 per share | โ | Jan 2, 2026 | Grant/Award | 224,080 | $0.00 | $0.00 | 2,732,700 | Direct | โ | View Details | |
Director | Common Stock, par value $0.00001 per share | โ | Jan 5, 2026 | Sale | 132,454 | $32.29 | $4,277,032.38 | 2,600,246 | Direct | โ | View Details | |
Director | Common Stock, par value $0.00001 per share | โ | Jan 5, 2026 | Sale | 53,279 | $33.38 | $1,778,266.54 | 2,546,967 | Direct | โ | View Details | |
Director | Common Stock, par value $0.00001 per share | โ | Jan 5, 2026 | Sale | 41,276 | $34.22 | $1,412,398.68 | 2,505,691 | Direct | โ | View Details | |
Director | Common Stock, par value $0.00001 per share | โ | Jan 5, 2026 | Sale | 6,400 | $35.07 | $224,423.04 | 2,499,291 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 2, 2026 | Grant/Award | 176,300 | $0.00 | $0.00 | 176,300 | Direct | โ | View Details |